| Preferred term . | Any grade . | Grade ≥3 . | |||
|---|---|---|---|---|---|
| N | 660 | ||||
| Patients with any ADR | 511 | (77.4) | 409 | (62.0) | |
| Hematologic ADRs | |||||
| Anemia* | 99 | (15.0) | 58 | (8.8) | |
| Leukopenia | 74 | (11.2) | 48 | (7.3) | |
| Febrile neutropenia* | 119 | (18.0) | 113 | (17.1) | |
| Neutropenia * | 324 | (49.1) | 263 | (39.8) | |
| Thrombocytopenia | 77 | (11.7) | 36 | (5.5) | |
| Bone marrow failure | 2 | (0.3) | 2 | (0.3) | |
| Non-hematologic ADRs | |||||
| Pneumonia | 6 | (0.9) | 5 | (0.8) | |
| Pyelonephritis | 3 | (0.5) | 3 | (0.5) | |
| Sepsis* | 4 | (0.6) | 4 | (0.6) | |
| Septic shock* | 3 | (0.5) | 3 | (0.5) | |
| Decreased appetite | 49 | (7.4) | 11 | (1.7) | |
| Peripheral neuropathy* | 10 | (1.5) | 2 | (0.3) | |
| Interstitial lung disease | 8 | (1.2) | 7 | (1.1) | |
| Pneumonitis | 2 | (0.3) | 2 | (0.3) | |
| Diarrhea* | 66 | (10.0) | 21 | (3.2) | |
| Nausea | 22 | (3.3) | 4 | (0.6) | |
| Vomiting | 11 | (1.7) | 3 | (0.5) | |
| Liver disorders | 3 | (0.5) | 3 | (0.5) | |
| Malaise | 40 | (6.1) | 3 | (0.5) | |
| Pyrexia | 22 | (3.3) | 4 | (0.6) | |
| Preferred term . | Any grade . | Grade ≥3 . | |||
|---|---|---|---|---|---|
| N | 660 | ||||
| Patients with any ADR | 511 | (77.4) | 409 | (62.0) | |
| Hematologic ADRs | |||||
| Anemia* | 99 | (15.0) | 58 | (8.8) | |
| Leukopenia | 74 | (11.2) | 48 | (7.3) | |
| Febrile neutropenia* | 119 | (18.0) | 113 | (17.1) | |
| Neutropenia * | 324 | (49.1) | 263 | (39.8) | |
| Thrombocytopenia | 77 | (11.7) | 36 | (5.5) | |
| Bone marrow failure | 2 | (0.3) | 2 | (0.3) | |
| Non-hematologic ADRs | |||||
| Pneumonia | 6 | (0.9) | 5 | (0.8) | |
| Pyelonephritis | 3 | (0.5) | 3 | (0.5) | |
| Sepsis* | 4 | (0.6) | 4 | (0.6) | |
| Septic shock* | 3 | (0.5) | 3 | (0.5) | |
| Decreased appetite | 49 | (7.4) | 11 | (1.7) | |
| Peripheral neuropathy* | 10 | (1.5) | 2 | (0.3) | |
| Interstitial lung disease | 8 | (1.2) | 7 | (1.1) | |
| Pneumonitis | 2 | (0.3) | 2 | (0.3) | |
| Diarrhea* | 66 | (10.0) | 21 | (3.2) | |
| Nausea | 22 | (3.3) | 4 | (0.6) | |
| Vomiting | 11 | (1.7) | 3 | (0.5) | |
| Liver disorders | 3 | (0.5) | 3 | (0.5) | |
| Malaise | 40 | (6.1) | 3 | (0.5) | |
| Pyrexia | 22 | (3.3) | 4 | (0.6) | |
*Priority survey item.
ADR, adverse drug reaction.
Data are shown as n (%).
| Preferred term . | Any grade . | Grade ≥3 . | |||
|---|---|---|---|---|---|
| N | 660 | ||||
| Patients with any ADR | 511 | (77.4) | 409 | (62.0) | |
| Hematologic ADRs | |||||
| Anemia* | 99 | (15.0) | 58 | (8.8) | |
| Leukopenia | 74 | (11.2) | 48 | (7.3) | |
| Febrile neutropenia* | 119 | (18.0) | 113 | (17.1) | |
| Neutropenia * | 324 | (49.1) | 263 | (39.8) | |
| Thrombocytopenia | 77 | (11.7) | 36 | (5.5) | |
| Bone marrow failure | 2 | (0.3) | 2 | (0.3) | |
| Non-hematologic ADRs | |||||
| Pneumonia | 6 | (0.9) | 5 | (0.8) | |
| Pyelonephritis | 3 | (0.5) | 3 | (0.5) | |
| Sepsis* | 4 | (0.6) | 4 | (0.6) | |
| Septic shock* | 3 | (0.5) | 3 | (0.5) | |
| Decreased appetite | 49 | (7.4) | 11 | (1.7) | |
| Peripheral neuropathy* | 10 | (1.5) | 2 | (0.3) | |
| Interstitial lung disease | 8 | (1.2) | 7 | (1.1) | |
| Pneumonitis | 2 | (0.3) | 2 | (0.3) | |
| Diarrhea* | 66 | (10.0) | 21 | (3.2) | |
| Nausea | 22 | (3.3) | 4 | (0.6) | |
| Vomiting | 11 | (1.7) | 3 | (0.5) | |
| Liver disorders | 3 | (0.5) | 3 | (0.5) | |
| Malaise | 40 | (6.1) | 3 | (0.5) | |
| Pyrexia | 22 | (3.3) | 4 | (0.6) | |
| Preferred term . | Any grade . | Grade ≥3 . | |||
|---|---|---|---|---|---|
| N | 660 | ||||
| Patients with any ADR | 511 | (77.4) | 409 | (62.0) | |
| Hematologic ADRs | |||||
| Anemia* | 99 | (15.0) | 58 | (8.8) | |
| Leukopenia | 74 | (11.2) | 48 | (7.3) | |
| Febrile neutropenia* | 119 | (18.0) | 113 | (17.1) | |
| Neutropenia * | 324 | (49.1) | 263 | (39.8) | |
| Thrombocytopenia | 77 | (11.7) | 36 | (5.5) | |
| Bone marrow failure | 2 | (0.3) | 2 | (0.3) | |
| Non-hematologic ADRs | |||||
| Pneumonia | 6 | (0.9) | 5 | (0.8) | |
| Pyelonephritis | 3 | (0.5) | 3 | (0.5) | |
| Sepsis* | 4 | (0.6) | 4 | (0.6) | |
| Septic shock* | 3 | (0.5) | 3 | (0.5) | |
| Decreased appetite | 49 | (7.4) | 11 | (1.7) | |
| Peripheral neuropathy* | 10 | (1.5) | 2 | (0.3) | |
| Interstitial lung disease | 8 | (1.2) | 7 | (1.1) | |
| Pneumonitis | 2 | (0.3) | 2 | (0.3) | |
| Diarrhea* | 66 | (10.0) | 21 | (3.2) | |
| Nausea | 22 | (3.3) | 4 | (0.6) | |
| Vomiting | 11 | (1.7) | 3 | (0.5) | |
| Liver disorders | 3 | (0.5) | 3 | (0.5) | |
| Malaise | 40 | (6.1) | 3 | (0.5) | |
| Pyrexia | 22 | (3.3) | 4 | (0.6) | |
*Priority survey item.
ADR, adverse drug reaction.
Data are shown as n (%).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
